HUE050070T2 - Új immunterápia többféle vérképzõszervi daganat, különösen krónikus limfoid leukémia (CLL) ellen - Google Patents
Új immunterápia többféle vérképzõszervi daganat, különösen krónikus limfoid leukémia (CLL) ellenInfo
- Publication number
- HUE050070T2 HUE050070T2 HUE15730135A HUE15730135A HUE050070T2 HU E050070 T2 HUE050070 T2 HU E050070T2 HU E15730135 A HUE15730135 A HU E15730135A HU E15730135 A HUE15730135 A HU E15730135A HU E050070 T2 HUE050070 T2 HU E050070T2
- Authority
- HU
- Hungary
- Prior art keywords
- cll
- blood
- lymphoid leukemia
- against several
- chronic lymphoid
- Prior art date
Links
- 206010028980 Neoplasm Diseases 0.000 title 1
- 239000008280 blood Substances 0.000 title 1
- 210000004369 blood Anatomy 0.000 title 1
- 208000032852 chronic lymphocytic leukemia Diseases 0.000 title 1
- 238000009169 immunotherapy Methods 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/0005—Vertebrate antigens
- A61K39/0011—Cancer antigens
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A61P35/02—Antineoplastic agents specific for leukemia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/57—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2
- A61K2039/572—Medicinal preparations containing antigens or antibodies characterised by the type of response, e.g. Th1, Th2 cytotoxic response
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Public Health (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical & Material Sciences (AREA)
- Oncology (AREA)
- Microbiology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Immunology (AREA)
- General Chemical & Material Sciences (AREA)
- Mycology (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Hematology (AREA)
- Peptides Or Proteins (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
- Micro-Organisms Or Cultivation Processes Thereof (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US201462014849P | 2014-06-20 | 2014-06-20 | |
| GBGB1411037.3A GB201411037D0 (en) | 2014-06-20 | 2014-06-20 | Novel immunotherapy against several tumors of the blood, in particular chronic lymphoid leukemai (CLL) |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HUE050070T2 true HUE050070T2 (hu) | 2020-11-30 |
Family
ID=51409910
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HUE15730135A HUE050070T2 (hu) | 2014-06-20 | 2015-06-17 | Új immunterápia többféle vérképzõszervi daganat, különösen krónikus limfoid leukémia (CLL) ellen |
Country Status (14)
| Country | Link |
|---|---|
| EP (2) | EP3157549B1 (hu) |
| JP (1) | JP6560261B2 (hu) |
| CA (1) | CA2950827A1 (hu) |
| DK (1) | DK3157549T3 (hu) |
| ES (1) | ES2802155T3 (hu) |
| GB (1) | GB201411037D0 (hu) |
| HU (1) | HUE050070T2 (hu) |
| LT (1) | LT3157549T (hu) |
| PL (1) | PL3157549T3 (hu) |
| PT (1) | PT3157549T (hu) |
| RS (1) | RS60592B1 (hu) |
| SI (1) | SI3157549T1 (hu) |
| TW (3) | TWI670282B (hu) |
| WO (1) | WO2015193359A2 (hu) |
Families Citing this family (23)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| GB201408255D0 (en) * | 2014-05-09 | 2014-06-25 | Immatics Biotechnologies Gmbh | Novel immunotherapy against several tumours of the blood, such as acute myeloid leukemia (AML) |
| EP4299136A3 (en) | 2015-12-16 | 2024-02-14 | Gritstone bio, Inc. | Neoantigen identification, manufacture, and use |
| MA55153A (fr) | 2016-02-19 | 2021-09-29 | Immatics Biotechnologies Gmbh | Nouveaux peptides et combinaison de peptides pour une utilisation dans l'immunothérapie contre le lymphome non hodgkinien et d'autres cancers |
| GB201602918D0 (en) | 2016-02-19 | 2016-04-06 | Immatics Biotechnologies Gmbh | Novel peptides and combination of peptides for use in immunotherapy against NHL and other cancers |
| GB201603987D0 (en) | 2016-03-08 | 2016-04-20 | Immatics Biotechnologies Gmbh | Uterine cancer treatments |
| MX2018012758A (es) | 2016-04-21 | 2019-01-31 | Immatics Biotechnologies Gmbh | Inmunoterapia contra el melanoma y otros tipos de cancer. |
| WO2017182395A1 (en) * | 2016-04-21 | 2017-10-26 | Immatics Biotechnologies Gmbh | Immunotherapy against melanoma and other cancers |
| DE102016005550A1 (de) | 2016-05-09 | 2017-11-09 | Emc Microcollections Gmbh | Adjuvans zur lnduzierung einer zellulären lmmunantwort |
| JP7075125B2 (ja) | 2016-05-25 | 2022-05-25 | イマティクス バイオテクノロジーズ ゲーエムベーハー | 標的としてのおよび胆嚢がんおよび胆管がんおよびその他のがんに対する免疫療法で使用するための新規ペプチド、ペプチド組み合わせ |
| GB201609193D0 (en) | 2016-05-25 | 2016-07-06 | Immatics Biotechnologies Gmbh | Novel peptides, combination of peptides as targets for use in immunotherapy against gallbladder cancer and cholangiocarcinoma and other cancers |
| CN107602682A (zh) * | 2016-07-07 | 2018-01-19 | 胡国田 | 一种多肽及其应用 |
| TWI796299B (zh) | 2016-08-26 | 2023-03-21 | 德商英麥提克生物技術股份有限公司 | 用於頭頸鱗狀細胞癌和其他癌症免疫治療的新型肽和支架 |
| KR102639592B1 (ko) | 2016-12-08 | 2024-02-21 | 이매틱스 바이오테크놀로지스 게엠베하 | 짝짓기가 향상된 t 세포 수용체 |
| DE102016123893A1 (de) | 2016-12-08 | 2018-06-14 | Immatics Biotechnologies Gmbh | T-Zellrezeptoren mit verbesserter Bindung |
| US10899819B2 (en) | 2017-04-10 | 2021-01-26 | Immatics Biotechnologies Gmbh | Peptides and combination of peptides for use in immunotherapy against leukemias and other cancers |
| KR20190137858A (ko) | 2017-04-10 | 2019-12-11 | 이매틱스 바이오테크놀로지스 게엠베하 | 백혈병 및 다른 암에 대한 면역요법에 사용하기 위한 펩티드 및 펩티드의 조합 |
| AU2018348165A1 (en) | 2017-10-10 | 2020-05-21 | Gritstone Bio, Inc. | Neoantigen identification using hotspots |
| EP3714275A4 (en) | 2017-11-22 | 2021-10-27 | Gritstone bio, Inc. | REDUCTION OF JUNCTION EPITOPIC PRESENTATION FOR NEOANTIGENS |
| DE102018107224A1 (de) | 2018-02-21 | 2019-08-22 | Immatics Biotechnologies Gmbh | Peptide und Kombinationen von Peptiden nicht-kanonischen Ursprungs zur Verwendung in der Immuntherapie gegen verschiedene Krebsarten |
| US10925947B2 (en) | 2018-06-29 | 2021-02-23 | Immatics Biotechnologies Gmbh | A*03 restricted peptides for use in immunotherapy against cancers and related methods |
| TW202019955A (zh) | 2018-07-31 | 2020-06-01 | 德商英麥提克生物技術股份有限公司 | B*07 限制肽和肽組合的抗癌免疫治療和相關方法 |
| EP3827022A1 (en) * | 2018-08-11 | 2021-06-02 | Baerlecken, Niklas | Autoantibodies binding to negative elongation factor e (nelf-e) for diagnosing sarcoidosis |
| CN109593125A (zh) * | 2018-12-12 | 2019-04-09 | 深圳市龙华区人民医院 | 基于前列腺癌干细胞标志物cd44的抗原表位多肽cd44-p1及其应用 |
Family Cites Families (35)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4440859A (en) | 1977-05-27 | 1984-04-03 | The Regents Of The University Of California | Method for producing recombinant bacterial plasmids containing the coding sequences of higher organisms |
| US4704362A (en) | 1977-11-08 | 1987-11-03 | Genentech, Inc. | Recombinant cloning vehicle microbial polypeptide expression |
| FI86437C (fi) | 1978-12-22 | 1992-08-25 | Biogen Inc | Foerfarande foer framstaellning av polypeptider med de antigena egenskaperna hos ett hepatitis b- virusantigen. |
| US4530901A (en) | 1980-01-08 | 1985-07-23 | Biogen N.V. | Recombinant DNA molecules and their use in producing human interferon-like polypeptides |
| US4342566A (en) | 1980-02-22 | 1982-08-03 | Scripps Clinic & Research Foundation | Solid phase anti-C3 assay for detection of immune complexes |
| US4678751A (en) | 1981-09-25 | 1987-07-07 | Genentech, Inc. | Hybrid human leukocyte interferons |
| US4766075A (en) | 1982-07-14 | 1988-08-23 | Genentech, Inc. | Human tissue plasminogen activator |
| US4582800A (en) | 1982-07-12 | 1986-04-15 | Hoffmann-La Roche Inc. | Novel vectors and method for controlling interferon expression |
| US4816567A (en) | 1983-04-08 | 1989-03-28 | Genentech, Inc. | Recombinant immunoglobin preparations |
| US4757006A (en) | 1983-10-28 | 1988-07-12 | Genetics Institute, Inc. | Human factor VIII:C gene and recombinant methods for production |
| US4677063A (en) | 1985-05-02 | 1987-06-30 | Cetus Corporation | Human tumor necrosis factor |
| US4810648A (en) | 1986-01-08 | 1989-03-07 | Rhone Poulenc Agrochimie | Haloarylnitrile degrading gene, its use, and cells containing the gene |
| US4897445A (en) | 1986-06-27 | 1990-01-30 | The Administrators Of The Tulane Educational Fund | Method for synthesizing a peptide containing a non-peptide bond |
| ES2108460T3 (es) | 1993-06-03 | 1997-12-16 | Therapeutic Antibodies Inc | Fragmentos de anticuerpos en terapeutica. |
| AUPM322393A0 (en) | 1993-12-24 | 1994-01-27 | Austin Research Institute, The | Mucin carbohydrate compounds and their use in immunotherapy |
| JP4767371B2 (ja) | 1996-01-17 | 2011-09-07 | インペリアル・イノベイションズ・リミテッド | 細胞障害性ｔリンパ球（ｃｔｌ）を用いた免疫療法 |
| US5849589A (en) | 1996-03-11 | 1998-12-15 | Duke University | Culturing monocytes with IL-4, TNF-α and GM-CSF TO induce differentiation to dendric cells |
| US6406705B1 (en) | 1997-03-10 | 2002-06-18 | University Of Iowa Research Foundation | Use of nucleic acids containing unmethylated CpG dinucleotide as an adjuvant |
| US20040191260A1 (en) | 2003-03-26 | 2004-09-30 | Technion Research & Development Foundation Ltd. | Compositions capable of specifically binding particular human antigen presenting molecule/pathogen-derived antigen complexes and uses thereof |
| EP2316950A1 (en) | 2000-03-27 | 2011-05-04 | Technion Research and Development Foundation, Ltd. | Single chain class I major histo-compatibility complexes, constructs encoding same and methods of generating same |
| EP2322228B1 (en) | 2000-06-05 | 2018-01-10 | Altor BioScience Corporation | T cell receptor fusion proteins and conjugates and methods of use thereof |
| AU2002218269A1 (en) * | 2000-11-15 | 2002-05-27 | Apoxis Sa | Proteins and dna sequences underlying these proteins used for treating inflammations |
| US7919467B2 (en) * | 2000-12-04 | 2011-04-05 | Immunotope, Inc. | Cytotoxic T-lymphocyte-inducing immunogens for prevention, treatment, and diagnosis of cancer |
| US6992176B2 (en) | 2002-02-13 | 2006-01-31 | Technion Research & Development Foundation Ltd. | Antibody having a T-cell receptor-like specificity, yet higher affinity, and the use of same in the detection and treatment of cancer, viral infection and autoimmune disease |
| JP2005533486A (ja) | 2002-02-20 | 2005-11-10 | ダイアックス、コープ | Ｍｈｃ−ペプチド複合体結合リガンド |
| AU2003271904B2 (en) | 2002-10-09 | 2009-03-05 | Adaptimmune Limited | Single chain recombinant T cell receptors |
| PT1558643E (pt) | 2002-11-09 | 2009-08-24 | Immunocore Ltd | Apresentação de um receptor das células t |
| GB0304068D0 (en) | 2003-02-22 | 2003-03-26 | Avidex Ltd | Substances |
| EP1766412B1 (en) * | 2004-05-21 | 2009-04-01 | The Institute for Systems Biology | Compositions and methods for quantification of serum glycoproteins |
| EP1806358B1 (en) | 2005-09-05 | 2010-03-17 | Immatics Biotechnologies GmbH | Tumor-associated peptides binding promiscuously to human leukocyte antigen (HLA) class II molecules |
| US20070248628A1 (en) * | 2005-12-06 | 2007-10-25 | Keller Lorraine H | Immunogens in cancer stem cells |
| US20090263574A1 (en) | 2008-04-21 | 2009-10-22 | Quinn Daniel E | Method of restoring an article |
| GB201006360D0 (en) | 2010-04-16 | 2010-06-02 | Immatics Biotechnologies Gmbh | Method for differentially quantifying naturally processed HLA-restricted peptides for cancer, autoimmune and infectious diseases immunotherapy development |
| CA2816225A1 (en) | 2010-10-26 | 2012-05-03 | Technion Research & Development Foundation Ltd. | Antibodies which bind soluble t-cell receptor ligands |
| WO2013057586A1 (en) | 2011-10-19 | 2013-04-25 | Oslo Universitetssykehus Hf | Compositions and methods for producing soluble t - cell receptors |
-
2014
- 2014-06-20 GB GBGB1411037.3A patent/GB201411037D0/en not_active Ceased
-
2015
- 2015-06-17 JP JP2016572509A patent/JP6560261B2/ja not_active Expired - Fee Related
- 2015-06-17 ES ES15730135T patent/ES2802155T3/es active Active
- 2015-06-17 EP EP15730135.9A patent/EP3157549B1/en active Active
- 2015-06-17 WO PCT/EP2015/063566 patent/WO2015193359A2/en active Application Filing
- 2015-06-17 SI SI201531301T patent/SI3157549T1/sl unknown
- 2015-06-17 RS RS20200910A patent/RS60592B1/sr unknown
- 2015-06-17 PL PL15730135T patent/PL3157549T3/pl unknown
- 2015-06-17 LT LTEP15730135.9T patent/LT3157549T/lt unknown
- 2015-06-17 CA CA2950827A patent/CA2950827A1/en not_active Abandoned
- 2015-06-17 HU HUE15730135A patent/HUE050070T2/hu unknown
- 2015-06-17 PT PT157301359T patent/PT3157549T/pt unknown
- 2015-06-17 DK DK15730135.9T patent/DK3157549T3/da active
- 2015-06-17 EP EP20170980.5A patent/EP3708185A3/en not_active Withdrawn
- 2015-06-18 TW TW104119833A patent/TWI670282B/zh not_active IP Right Cessation
- 2015-06-18 TW TW108109176A patent/TW201930347A/zh unknown
- 2015-06-18 TW TW109104580A patent/TW202024125A/zh unknown
Also Published As
| Publication number | Publication date |
|---|---|
| WO2015193359A2 (en) | 2015-12-23 |
| ES2802155T3 (es) | 2021-01-15 |
| JP2017525336A (ja) | 2017-09-07 |
| EP3708185A2 (en) | 2020-09-16 |
| WO2015193359A3 (en) | 2016-02-25 |
| EP3157549B1 (en) | 2020-04-29 |
| JP6560261B2 (ja) | 2019-08-14 |
| DK3157549T3 (da) | 2020-06-22 |
| GB201411037D0 (en) | 2014-08-06 |
| TW201930347A (zh) | 2019-08-01 |
| PL3157549T3 (pl) | 2020-12-14 |
| RS60592B1 (sr) | 2020-08-31 |
| PT3157549T (pt) | 2020-07-01 |
| LT3157549T (lt) | 2020-08-10 |
| TW201613956A (en) | 2016-04-16 |
| SI3157549T1 (sl) | 2020-08-31 |
| TW202024125A (zh) | 2020-07-01 |
| EP3157549A2 (en) | 2017-04-26 |
| EP3708185A3 (en) | 2020-11-04 |
| CA2950827A1 (en) | 2015-12-23 |
| TWI670282B (zh) | 2019-09-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| PT3157549T (pt) | Nova imunoterapia contra vários tumores do sangue, em particular a leucemia linfoide crónica (llc) | |
| DK3140319T3 (en) | Novel immunotherapy against several tumors of the blood, such as acute myeloid leukemia (aml) | |
| HK1222121A1 (zh) | 用於治療多種腫瘤 例如包括 在內的肺癌 的新型免疫療法 | |
| EP3240801A4 (en) | Combination tumor immunotherapy | |
| GB201507030D0 (en) | Immunotherapy against lung cancers, in particular NSCLC | |
| EP3094342A4 (en) | Anti-tumor therapy | |
| IL280565A (en) | New immunotherapy against various tumors such as lung cancer which includes nsclc | |
| EP3157553A4 (en) | Treatment for chronic lymphocytic leukemia (cll) | |
| IL271367A (en) | Innovative immunotherapy against blood tumors such as acute leukemia in the spinal cord | |
| IL249533A0 (en) | Treatment of chronic lymphocytic leukemia | |
| GB201403297D0 (en) | Novel immunotherapy against several tumors, such as lung cancer, including NSCLC | |
| GB201313987D0 (en) | Novel immunotherapy against several tumors, such as lung cancer including NSCLC |